Food & Beverages Global On demand · 24-48h

Global Heat Stable Postbiotic Powder Ingredients Market Strategic Research Report

Global Heat Stable Postbiotic Powder Ingredients Market Stra…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Heat Stable Postbiotic Powder Ingredients Market
$1472025
10.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Yeast Fermentate Postbiotic, Heat-killed Lactobacillus Postbiotic, Bifidobacterium-derived Postbiotic, Multi-strain Postbiotic Blend

By Application: Functional Foods and Beverages, Dietary Supplements, Infant and Senior Nutrition, Pet Food and Treats

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: ADM (US), Cargill (US), DSM-Firmenich AG(CH), Kerry Group (IE), IFF Health (US), Novonesis (DK), Lallemand Health Solutions (CA), Lesaffre(FR), Probi (SE), Morinaga Milk Industry (JP), Yakult Honsha (JP), Kirin Holdings (JP), Angel Yeast (CN), BYHEALTH (CN), InnoOrigin Biological (CN)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 121 pages
Market size 2025
$147
Million USD
Forecast CAGR
10.9%
2025-2032
Forecast 2032
$303.3
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Heat Stable Postbiotic Powder Ingredients market size is predicted to grow from US$ 147 million in 2025 to US$ 311 million in 2032; it is expected to grow at a CAGR of 10.9% from 2026 to 2032.

In 2025, global sales volume for heat-stable postbiotic powder ingredients is projected to reach approximately 6,000 tons, with an average price of around $25,000 per ton.

Heat-stable postbiotic powder ingredients consist of a combination of inactivated microbial components and metabolic products derived from probiotics, yeasts, or other microorganisms through processes involving fermentation, inactivation, drying, and standardization. Characterized by their independence from live microbial viability, tolerance to heat processing, shelf-life stability, and high compatibility with various formulations, these ingredients are utilized in functional foods, dietary supplements, infant and child nutrition, and pet nutrition products. The upstream supply chain primarily comprises microbial strain banks, fermentation media, spray drying/freeze-drying equipment, and quality testing services; the downstream market consists mainly of brands in the food and beverage, nutritional supplement, dairy, bakery, pet food, and health product sectors.

Global key Heat Stable Postbiotic Powder Ingredients players cover ADM (US), Cargill (US), DSM-Firmenich AG(CH), Kerry Group (IE), IFF Health (US), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Heat Stable Postbiotic Powder Ingredients market?

What factors are driving Heat Stable Postbiotic Powder Ingredients market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Heat Stable Postbiotic Powder Ingredients market opportunities vary by end market size?

How does Heat Stable Postbiotic Powder Ingredients break out by Type, by Application?

This report presents a comprehensive overview of the global Heat Stable Postbiotic Powder Ingredients market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Yeast Fermentate Postbiotic
  • Heat-killed Lactobacillus Postbiotic
  • Bifidobacterium-derived Postbiotic
  • Multi-strain Postbiotic Blend

Segment by Heat Resistance Temperature

  • Heat Stability 80-100℃
  • Heat Stability > 100℃

Segment by Functional Category

  • Immune Support Grade
  • Gut Health Grade
  • Infant Nutrition Grade
  • Pet Nutrition Grade

Segment by Application

  • Functional Foods and Beverages
  • Dietary Supplements
  • Infant and Senior Nutrition
  • Pet Food and Treats

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Heat Stable Postbiotic Powder Ingredients market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Functional Foods and Beverages, Dietary Supplements, Infant and Senior Nutrition evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Heat Stable Postbiotic Powder Ingredients Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$147
2025
Forecast
$303.3
2032
CAGR
10.9%
2025–2032
Regiones
5
global
Key companies
ADM (US)Cargill (US)DSM-Firmenich AG(CH)Kerry Group (IE)IFF Health (US)Novonesis (DK)Lallemand Health Solutions (CA)Lesaffre(FR)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Yeast Fermentate PostbioticHeat-killed Lactobacillus PostbioticBifidobacterium-derived PostbioticMulti-strain Postbiotic Blend
By Application
Functional Foods and BeveragesDietary SupplementsInfant and Senior NutritionPet Food and Treats

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Yeast Fermentate Postbiotic
  • 3.1.3 Heat-killed Lactobacillus Postbiotic
  • 3.1.4 Bifidobacterium-derived Postbiotic
  • 3.1.5 Multi-strain Postbiotic Blend
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Functional Foods and Beverages
  • 4.1.3 Dietary Supplements
  • 4.1.4 Infant and Senior Nutrition
  • 4.1.5 Pet Food and Treats
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 ADM (US)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cargill (US)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 DSM-Firmenich AG(CH)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Kerry Group (IE)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 IFF Health (US)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Novonesis (DK)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Lallemand Health Solutions (CA)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Lesaffre(FR)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Probi (SE)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Morinaga Milk Industry (JP)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Yakult Honsha (JP)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Kirin Holdings (JP)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Angel Yeast (CN)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 BYHEALTH (CN)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 InnoOrigin Biological (CN)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Heat Stable Postbiotic Powder Ingredients market size?
The global Heat Stable Postbiotic Powder Ingredients market is estimated at US$ 147 million in 2025 (base year) and is projected to reach US$ 311 million by 2032.
What growth rate is expected for the Heat Stable Postbiotic Powder Ingredients market through 2032?
The market is expected to grow at a CAGR of 10.9% from 2026 to 2032, expanding from US$ 147 million in 2025 to US$ 311 million in 2032, roughly 2.1 times its base-year value.
How is Heat Stable Postbiotic Powder Ingredients defined?
In 2025, global sales volume for heat-stable postbiotic powder ingredients is projected to reach approximately 6,000 tons, with an average price of around $25,000 per ton.
What are the main segments of the Heat Stable Postbiotic Powder Ingredients market by type?
By type, the market is segmented into Yeast Fermentate Postbiotic, Heat-killed Lactobacillus Postbiotic, Bifidobacterium-derived Postbiotic and Multi-strain Postbiotic Blend.
Which applications drive demand in the Heat Stable Postbiotic Powder Ingredients market?
Key applications covered include Functional Foods and Beverages, Dietary Supplements, Infant and Senior Nutrition and Pet Food and Treats.
Who are the key players in the Heat Stable Postbiotic Powder Ingredients market?
Key players profiled include ADM (US), Cargill (US), DSM-Firmenich AG(CH), Kerry Group (IE), IFF Health (US), Novonesis (DK), Lallemand Health Solutions (CA) and Lesaffre(FR), among 15 companies covered in total.
Which regions and countries are covered for Heat Stable Postbiotic Powder Ingredients?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Heat Stable Postbiotic Powder Ingredients market?
What factors are driving Heat Stable Postbiotic Powder Ingredients market growth, globally and by region?
Who should buy the Heat Stable Postbiotic Powder Ingredients market report?
The report is intended for manufacturers and solution providers, distributors and end users in Functional Foods and Beverages, Dietary Supplements and Infant and Senior Nutrition, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Heat Stable Postbiotic Powder Ingredients market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.